#cancercalculus résultats de recherche

6⃣ Η διεθνής έρευνα #CancerCalculus του @ICIJorg τεκμηριώνει, με τη συμμετοχή του #ReportersUnited και 46 ακόμη ΜΜΕ, τις πολλαπλές μεθοδεύσεις της αμερικανικής εταιρείας MSD για τη διατήρηση των υπέρογκων τιμών του Keytruda, ενός φαρμάκου αποτελεσματικού για πολλές μορφές

ICIJ's #CancerCalculus investigation reveals pharmaceutical giant Merck has built a fortress of patents, traded in secrecy and relentlessly lobbied to guard its revenue kingpin Keytruda. Read the main story: buff.ly/vlcRIlc

ICIJ and its #CancerCalculus media partners filed dozens of public records requests, interviewed investigators and experts, approached illegal sellers, and found that not only patients — but hospitals — have become unwitting customers of counterfeiters. bit.ly/4msaXcm

Keytruda has transformed cancer care by extending survival for patients with advanced melanoma and other hard-to-treat tumors. But the #CancerCalculus reveals the hurdles patients have to go through to access the treatment around the world. bit.ly/4vyyX1Y

NEW: Lawmakers and experts in several countries have called for pharmaceutical companies to be more transparent about drug pricing and tax dealings following revelations from ICIJ’s global #CancerCalculus investigation. icij.org/investigations… by @icijorg

Geheim-Business Krebs: Was sagt Sabine Vogler, Österreichs führende Expertin für Medikamentenpreise, zur intransparenten Arzneimittel-Beschaffung im Spitalsbereich? Und wo könnte man ansetzen? #CancerCalculus @ICIJorg @profilonline - profil.at/geheime-medika…

Cancer is a growing public health threat, responsible for nearly 1 in 6 deaths worldwide. Projections show cancer rates rising, particularly in lower-income countries where the lifesaving cancer drug Keytruda remains largely unaffordable. #CancerCalculus bit.ly/4cJ7DoO

Lawmakers and experts in several countries have called for pharmaceutical companies to be more transparent about drug pricing and tax dealings following revelations from ICIJ’s #CancerCalculus. Read the updates: bit.ly/4cyx8sQ

NEW: A ‘burgeoning black market’, inflated dosing and the over-judicialization of health care: reporters around the world assess impact of high priced cancer drug Keytruda. #CancerCalculus icij.org/investigations… by @icijorg

ICYMI: Merck’s blockbuster cancer drug Keytuda topped $200,000 a year under Trump #CancerCalculus icij.org/investigations… by @icijorg

ICIJ's #CancerCalculus investigation brought together reporters worldwide to shed new light on strategies Merck & Co. has used to widen the use of its blockbuster cancer drug and protect its monopoly. Here are some of the stories from our media partners: bit.ly/4txgOju

ICIJ's #CancerCalculus investigation reveals pharmaceutical giant Merck has built a fortress of patents, traded in secrecy and relentlessly lobbied to guard its revenue kingpin Keytruda. Read our main story: bit.ly/4tKl7Yg

6⃣ Η διεθνής δημοσιογραφική έρευνα #CancerCalculus του @ICIJorg τεκμηριώνει, με τη συμμετοχή του #ReportersUnited και 46 ακόμη ΜΜΕ, τις πολλαπλές μεθοδεύσεις της αμερικανικής εταιρείας #MSD για τη διατήρηση των υπέρογκων τιμών του #Keytruda, ενός φαρμάκου αποτελεσματικού για

In case you’re still wondering: What is Keytruda? Why is it so expensive? What data was used in the #CancerCalculus investigation? Find answers to these questions and more in our FAQs: bit.ly/4th7XCi

Northern Colorado's newest reservoir to be filled following uranium detection youtu.be/zoKRfaRtJVE?si… WE ALL LIVE DOWNSTREAM! #CancerCalculus #CANCER ASSHOLES

A new U.S. Senate report found that Merck & Co.’s blockbuster cancer drug Keytruda — the subject of ICJI's #CancerCalculus investigation — has risen in price to $210,000 for one year’s treatment under President Donald Trump. bit.ly/4sHmE0r

As a result, a sky-high price of a potentially lifesaving cancer drug puts it out of reach for many health systems, forcing patients who have the resources — and stamina — to fight for the right to treat their disease: icij.org/investigations… #CancerCalculus @icijorg

Se vincula con la investigación internacional #CancerCalculus liderada por @ICIJorg sobre las estrategias y lobby implementados por el laboratorio multinacional de origen norteamericano Merck & Co (conocida como MSD en Argentina) para garantizar extender su monopolio sobre

A estos médicos de hospitales públicos les toca «jugar a ser Dios» para decidir a quién suministrarle #LaMedicinaDelMillón, uno de los tratamientos contra el cáncer más efectivos del mundo, pero con un precio inaccesible para la mayoría. #CancerCalculus lnk.bio/s/a2daf

Pacientes con #cáncer recibieron #Keytruda falsificado en @IMSS_Bienestar e @ISSSTE_mx. La investigación #CancerCalculus documentó 11,479 frascos de lotes falsos aplicados en hospitales públicos. Caso en #Mérida: paciente sufrió temblores y parálisis @Claudiashein @Cofepris

#CancerCalculus - @ICIJorg @dw_turkce, araştırma kapsamında Türkiye'deki 50 dava dosyasını inceledi #Keytruda'nın fiyatı Türkiye piyasasına girdiği Temmuz 2016'dan bu yana 20 kez güncellendi. Bu süre zarfında fiyatı %850 arttı ✍️ Yeni araştırma yayında: dw.com/tr/t%C3%BCrkiy…

6⃣ Η διεθνής δημοσιογραφική έρευνα #CancerCalculus του @ICIJorg τεκμηριώνει, με τη συμμετοχή του #ReportersUnited και 46 ακόμη ΜΜΕ, τις πολλαπλές μεθοδεύσεις της αμερικανικής εταιρείας #MSD για τη διατήρηση των υπέρογκων τιμών του #Keytruda, ενός φαρμάκου αποτελεσματικού για

„Keytruda“ ist jenes Medikament, für das die Landesspitäler am meisten Geld ausgeben. Vieles rund um das Krebs-Mittel wird wie ein Geheimnis behandelt. @profilonline und @derStandardat nutzen das IFG, um Informationen zu erhalten. #CancerCalculus @ICIJorg profil.at/investigativ/g…

#CancerCalculus 30’dan fazla ülkede 100’den fazla gazetecinin bir yıllık araştırması @dw_turkce’nin @ICIJorg ile ortak araştırması, Merck’in Keytruda stratejilerinin kanser tedavisinde küresel eşitsizliği derinleştirdiğini ortaya koyuyor ✍️ dw.com/tr/hayat-uzata…

Alleine Wien gibt 60 Mio. €/Jahr für ein einziges Medikament aus - das Krebsmittel Keytruda. Zu Beschaffungsdetails mauern die Spitalsbetreiber der Länder. @profilonline und @derStandardat ziehen für mehr Transparenz vor Gericht. #CancerCalculus @ICIJorg profil.at/investigativ/g…

#CancerCalculus araştırmasına göre, Keytruda'nın yüksek fiyatı hastaları dava süreçlerine iterken başka bir riske kapıyı aralıyor: Sahte reçete, bavul ticareti ve kaçak ilaçlar #Keytruda'nın kara yüzü: Sahtecilik ve bavul ticareti @ICIJorg-@dw_turkce ✍️ dw.com/tr/keytrudan%C…

💊 Merck hizo de Keytruda algo más que un medicamento contra el cáncer: lo convirtió en un negocio blindado por patentes, precios desorbitados. tinyurl.com/j7ru5429 #CancerCalculus una investigación liderada por The International Consortium of Investigative Journalists

Reporting by #CancerCalculus media partners across five continents paints a picture of deep and dangerous inequity: In Guatemala, one doctor dealing with limited access to Keytruda had to choose two among his many patients to receive the cancer drug. icij.org/investigations…

Pacientes con #cáncer recibieron #Keytruda falsificado en @IMSS_Bienestar e @ISSSTE_mx. La investigación #CancerCalculus documentó 11,479 frascos de lotes falsos aplicados en hospitales públicos. Caso en #Mérida: paciente sufrió temblores y parálisis @Claudiashein @Cofepris